Klotho, an anti-senescence related gene, is frequently inactivated through promoter hypermethylation in colorectal cancer

Tumor Biology

Volumn 32, Issue 4, 2011, Pages 729-735

  Pan, Jie ^a,b   Zhong, Jing ^a   Gan, Li Hong ^a   Chen, Shu Jie ^b   Jin, Hong Chuan ^b   Wang, Xian ^b   Wang, Liang Jing ^a  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b ZHEJIANG UNIVERSITY   (China)

Author keywords

Colorectal Cancer; Klotho; Promoter methylation

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; GENOMIC DNA; MESSENGER RNA; TRICHOSTATIN A;

ADULT; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CANCER TISSUE; CELL CYCLE ARREST; CELL CYCLE S PHASE; CLINICAL ARTICLE; COLORECTAL CANCER; COLORECTAL CARCINOMA; CONTROLLED STUDY; CPG ISLAND; DNA METHYLATION; DOWN REGULATION; FEMALE; GENE EXPRESSION; GENE FUNCTION; GENE INACTIVATION; GENE SILENCING; GENETIC ANALYSIS; HUMAN; HUMAN CELL; HUMAN TISSUE; KLOTHO GENE; MALE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROMOTER REGION; TUMOR SUPPRESSOR GENE;

EID: 80052332092     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-011-0174-5     Document Type: Article

References (31)

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer statistics, 2009. CA Cancer J Clin. 2009;59:225-49.
2. Kamangar F, Dores GM, Anderson WF. Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. J Clin Oncol. 2006;24:2137-50. (Pubitemid 46655601)
3. Ahnen DJ. The american college of gastroenterology emily couric lecture - the adenoma-carcinoma sequence revisited: has the era of genetic tailoring finally arrived?AmJ Gastroenterol. 2011;106:190-8.
4. Grady WM, Carethers JM. Genomic and epigenetic instability in colorectal cancer pathogenesis. Gastroenterology. 2008;135:1079-99.
5. Wong JJ, Hawkins NJ, Ward RL. Colorectal cancer: a model for epigenetic tumorigenesis. Gut. 2007;56:140-8. (Pubitemid 46044900)
6. Esteller M. Epigenetics in cancer. N Engl J Med. 2008;358:1148-59.
7. Jones PA, Baylin SB. The epigenomics of cancer. Cell. 2007;128:683-92. (Pubitemid 46273572)
8. Ang PW, Loh M, Liem N, Lim PL, Grieu F, et al. Comprehensive profiling of DNA methylation in colorectal cancer reveals subgroups with distinct clinicopathological and molecular features. BMC Cancer. 2010;10:227-34.
9. Petko Z, Ghiassi M, Shuber A, Gorham J, Smalley W, et al. Aberrantly methylated CDKN2A, MGMT, and MLH1 in colon polyps and in fecal DNA from patients with colorectal polyps. Clin Cancer Res. 2005;11:1203-9. (Pubitemid 40175772)
10. Herman JG, Merlo A, Mao L, Lapidus RG, Issa JP, Davidson NE, et al. Inactivation of the CDKN2/p16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers. Cancer Res. 1995;55:4525-30.
11. Lee BB, Lee EJ, Jung EH, Chun HK, Chang DK, Song SY, et al. Aberrant methylation of APC, MGMT, RASSF2A, and Wif-1 genes in plasma as a biomarker for early detection of colorectal cancer. Clin Cancer Res. 2009;15:6185-91.
12. Wang LJ, Jin HC, Wang X, Lam EK, Zhang JB, Liu X, et al. ZIC1 is downregulated through promoter hypermethylation in gastric cancer. Biochem Biophys Res Commun. 2009;379:959-63.
13. Liu X, Wang X, Zhang J, Lam EK, Shin VY, Cheng AS, et al. Warburg effect revisited: an epigenetic link between glycolysis and gastric carcinogenesis. Oncogene. 2010;29:442-50.
14. Liu X, Lam EK, Wang X, Zhang J, Cheng YY, Lam YW, et al. Promoter hypermethylation mediates downregulation of thiamine receptor SLC19A3 in gastric cancer. Tumour Biol. 2009;30:242-8.
15. Wang X, Lau KK, So LK, Lam YW. CHD5 is down-regulated through promoter hypermethylation in gastric cancer. J Biomed Sci. 2009;16:95.
16. Kuro-o M, Matsumura Y, Aizawa H, Kawaguchi H, Suga T, Utsugi T. Mutation of the mouse klotho gene leads to a syndrome resembling ageing. Nature. 1997;390:45-51. (Pubitemid 27494749)
17. Kurosu H, Yamamoto M, Clark JD, Pastor JV, Nandi A, Gurnani P, et al. Suppression of aging in mice by the hormone Klotho. Science. 2005;309:1829-33. (Pubitemid 41325087)
18. Wang YA. Klotho, the long sought-after elixir and a novel tumor suppressor? Cancer Biol Ther. 2006;5:20-1. (Pubitemid 43234972)
19. Wolf I, Levanon-Cohen S, Bose S, Ligumsky H, Sredni B, Kanety H, et al. Klotho: a tumor suppressor and a modulator of the IGF-1 and FGF pathways in human breast cancer. Oncogene. 2008;27:7094-105.
20. Chen B, Wang X, Zhao W, Wu J. Klotho inhibits growth and promotes apoptosis in human lung cancer cell line A549. J Exp Clin Cancer Res. 2010;29:99-106.
21. Lee J, Jeong DJ, Kim J, Lee S, Park JH, Chang B, et al. The antiaging gene KLOTHO is a novel target for epigenetic silencing in human cervical carcinoma. Mol Cancer. 2010;9:109-18.
22. Hoeijmakers JH. DNA damage, aging, and cancer. N Engl J Med. 2009;361:1475-85.
23. Collado M, Serrano M. Senescence in tumours: evidence from mice and humans. Nat Rev Cancer. 2010;10:51-7.
24. Pollak M. Insulin and insulin-like growth factor signalling in neoplasia. Nat Rev Cancer. 2008;8:915-28.
25. Palmqvist R, Hallmans G, Rinaldi S, Biessy C, Stenling R, Riboli E, et al. Plasma insulin-like growth factor 1, insulin-like growth factor binding protein 3, and risk of colorectal cancer: a prospective study in northern Sweden. Gut. 2002;50:642-6. (Pubitemid 34407490)
26. Yavari K, Taghikhani M, Ghannadi Maragheh M, Mesbah-Namin SA, Babaei MH. Downregulation of IGF-IR expression by RNAi inhibits proliferation and enhances chemosensitization of human colon cancer cells. Int J Colorectal Dis. 2010;25:9-16.
27. de Oliveira RM. Klotho RNAi induces premature senescence of human cells via a p53/p21 dependent pathway. FEBS Lett. 2006;580:5753-8.
28. Liu H, Fergusson MM, Castilho RM, Liu J, Cao L, Chen J, et al. Augmented Wnt signaling in a mammalian model of accelerated aging. Science. 2007;317:803-6. (Pubitemid 47257917)
29. Wang LJ, Wang X, Wang XJ, Pan J, Zhang SJ, et al. Klotho is silenced through promoter hypermethylation in gastric cancer. Am J Cancer Res. 2011;1:111-9.
30. Groden J. Touch and go: mediating cell-to-cell interactions and Wnt signaling in gastrointestinal tumor formation. Gastroenterology. 2004;119:1161-4.
31. Schneikert J, Behrens J. The canonical Wnt signalling pathway and its APC partner in colon cancer development. Gut. 2007;56:417-25. (Pubitemid 46579774)